Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
4.670
-0.050 (-1.06%)
Nov 17, 2026, 3:04 PM CST

SHE:002252 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3361,4012,9834,0013,9782,747
Short-Term Investments
853.03705.31----
Trading Asset Securities
---197.41237.77219.38
Cash & Short-Term Investments
2,1892,1072,9834,1984,2162,966
Cash Growth
4.45%-29.37%-28.95%-0.41%42.11%33.90%
Accounts Receivable
2,6212,2231,810774.08915.44649.52
Other Receivables
91.192.813.319.812.021.21
Receivables
2,7122,3161,814783.88917.46650.73
Inventory
5,6255,3664,2933,6673,2693,173
Prepaid Expenses
-58.637.70.070.10.14
Other Current Assets
121.77103.93160.925.9271.4181.69
Total Current Assets
10,6489,9519,2578,6758,4736,872
Property, Plant & Equipment
2,6522,6621,9221,4531,2821,279
Long-Term Investments
14,89116,00416,77716,17715,70213,878
Goodwill
8,1998,1995,0735,0734,7034,900
Other Intangible Assets
717.38732.55485.01233.85175.49163.18
Long-Term Deferred Tax Assets
91.4293.5275.1489.8183.55104.27
Long-Term Deferred Charges
24.6929.7328.4721.2925.7828.97
Other Long-Term Assets
504.28108.7112.22205.341311.54
Total Assets
37,72837,78133,63131,92830,45827,237

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
296.08343.021,0761,6511,130956.29
Accrued Expenses
146.04362.09341.83289.17275.36234.64
Short-Term Debt
1,1991,309----
Current Portion of Long-Term Debt
60.37107.93----
Current Portion of Leases
-3.414.610.411.984.09
Current Income Taxes Payable
89.9345.3525.9494.5791.0353.53
Current Unearned Revenue
7.33.544.6922.6491.7628.69
Other Current Liabilities
351.16561.52198.18186.9734.5429.38
Total Current Liabilities
2,1502,7361,6522,2451,6251,307
Long-Term Debt
2,9732,473----
Long-Term Leases
8.9410.3912.991.491.854.16
Long-Term Unearned Revenue
20.4613.6110.969.4912.7715.2
Long-Term Deferred Tax Liabilities
40.1244.8914.8216.025.346.44
Other Long-Term Liabilities
46.6846.9-7.06--
Total Liabilities
5,2395,3251,6912,2791,6451,332

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
6,5936,6386,6386,6456,7416,741
Additional Paid-In Capital
13,78214,04214,05813,80514,56014,560
Retained Earnings
12,88012,11810,8599,1107,5335,843
Treasury Stock
-297.1-522.95-77.18-182.92--
Comprehensive Income & Other
-468.68180.85448.62255.67-15.72-1,241
Total Common Equity
32,48932,45631,92629,63428,81925,902
Minority Interest
--14.4615.86-5.371.72
Shareholders' Equity
32,48932,45631,94129,65028,81325,904
Total Liabilities & Equity
37,72837,78133,63131,92830,45827,237

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4,2413,90417.591.913.828.25
Net Cash (Debt)
-2,052-1,7982,9654,1964,2122,958
Net Cash Growth
---29.34%-0.36%42.38%34.00%
Net Cash Per Share
-0.31-0.270.450.640.620.44
Filing Date Shares Outstanding
6,6196,5576,6176,6056,7416,741
Total Common Shares Outstanding
6,6196,5576,6176,6056,7416,741
Working Capital
8,4997,2157,6066,4316,8495,566
Book Value Per Share
4.914.954.834.494.283.84
Tangible Book Value
23,57323,52426,36824,32723,94020,839
Tangible Book Value Per Share
3.563.593.993.683.553.09
Buildings
-2,1941,6611,3431,1951,146
Machinery
-1,5161,2871,2161,1321,074
Construction In Progress
-393.01289.21134.0374.1926.89